Pages that link to "Clopidogrel"
Jump to navigation
Jump to search
The following pages link to Clopidogrel:
Displayed 427 items.
- Bleeding (Excessive) (← links)
- Leg pain (← links)
- Preparation of the patient for PCI (← links)
- PCI in the patient at risk of bleeding (← links)
- Post PCI management (← links)
- Today in Medicine: Mixed Long-term Results for Sirolimus-Eluting Stent Implantation in Diabetic Patients (← links)
- The WikiDoc Living Textbook of Cardiology (← links)
- PCI in The Patient With Resistance to Aspirin (← links)
- Cardiodruglist (patient information) (← links)
- Bupropion (← links)
- It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007 (← links)
- Pharmacotherapy to Support PCI (← links)
- Antiplatelet therapy to support PCI (← links)
- Antithrombin therapy to support PCI (← links)
- The Living Guidelines: UA/NSTEMI Antiplatelet Therapy Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Antiplatelet Therapy Suggest Revisions to the CLASS IIa Guidelines (← links)
- Stent thrombosis Relation to drug eluting stents (← links)
- Stent thrombosis relationship to discontinuation of antiplatelet therapy (← links)
- Platelet (← links)
- Wiskott-Aldrich syndrome (← links)
- List of drugs: Cj-Cl (← links)
- List of bestselling drugs (← links)
- P2Y receptor (← links)
- P2Y12 (← links)
- Drug eluting stent (← links)
- Mitral valve replacement (← links)
- Nesiritide (← links)
- Prostacyclin (← links)
- Beraprost (← links)
- Prostaglandin analogue (← links)
- Coagulation (← links)
- Tissue plasminogen activator (← links)
- Anistreplase (← links)
- Bleeding diathesis (← links)
- Hirudin (← links)
- Danaparoid (← links)
- CYP3A4 (← links)
- Urokinase (← links)
- CYP2C19 (← links)
- CYP2B6 (← links)
- Adenosine diphosphate (← links)
- Citrate (← links)
- Pregnancy category (← links)
- Dermatan sulfate (← links)
- Anisindione (← links)
- Bivalirudin (← links)
- Clopidogrel (← links)
- Esomeprazole (injection) (← links)
- Nifedipine (← links)
- Omeprazole (← links)
- Pantoprazole (oral) (← links)
- Rabeprazole (← links)
- Fibrinolysin (← links)
- Tioclomarol (← links)
- Picotamide (← links)
- EDTA (← links)
- Triflusal (← links)
- Aloxiprin (← links)
- Thrombolytic drug (← links)
- Streptokinase (← links)
- Ximelagatran (← links)
- Low molecular weight heparin (← links)
- Anticoagulant (← links)
- Coumatetralyl (← links)
- Direct thrombin inhibitor (← links)
- Ancrod (← links)
- Acenocoumarol (← links)
- Phenindione (← links)
- Apixaban (← links)
- Carotid artery dissection (← links)
- Antiplatelet drug (← links)
- Clorindione (← links)
- Grape seed extract (← links)
- Glycoprotein IIb/IIIa inhibitors (← links)
- Blockbuster drug (← links)
- Prasugrel (← links)
- History of invasive and interventional cardiology (← links)
- Plateletpheresis (← links)
- Rash (← links)
- Drotrecogin alfa (← links)
- CHADS2 score (← links)
- ATC code B01 (← links)
- Saruplase (← links)
- Brinase (← links)
- Indobufen (← links)
- Cloricromen (← links)
- Carbasalate calcium (← links)
- Ditazole (← links)
- Bemiparin (← links)
- Parnaparin (← links)
- Tinzaparin (← links)
- Sulodexide (← links)
- Ethyl biscoumacetate (← links)
- Diphenadione (← links)
- Nadroparin (← links)
- Glycoprotein IIb/IIIa (← links)
- Artificial heart valve (← links)
- Left main coronary artery (← links)
- Dicumarol (← links)
- Phenprocoumon (← links)
- Desirudin (← links)
- Chronic stable angina overview (← links)
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: Oral Antiplatelet Therapy View the Current CLASS IIb Guidelines (← links)
- The Living Guidelines: Oral Antiplatelet Therapy Suggest Revisions to the CLASS IIb Guidelines (← links)
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS I Guidelines (← links)
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS IIa Guidelines (← links)
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS IIa Guidelines (← links)
- ST elevation myocardial infarction pre-hospital care (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy Suggest Revisions to the CLASS IIb Guidelines (← links)
- ST elevation myocardial infarction secondary prevention (← links)
- ST elevation myocardial infarction aspirin therapy (← links)
- The Living Textbook of Cardiovascular Pharmacology (← links)
- ST elevation myocardial infarction thienopyridine therapy (← links)
- ST elevation myocardial infarction glycoprotein IIbIIIa inhibition (← links)
- ST elevation myocardial infarction coronary artery bypass grafting (← links)
- COMMIT-CCS 2 (← links)
- Jacko test (← links)
- Adenosine A1 receptor (← links)
- PCI in the patient in cardiogenic shock (← links)
- ST elevation myocardial infarction primary percutaneous coronary intervention (← links)
- Retroperitoneal hematoma (← links)
- Plasminogen activator (← links)
- TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis (← links)
- Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients (← links)
- High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry (← links)
- Reloading With Clopidogrel Improves Clinical Outcomes in Patients with Acute Coronary Syndromes: ARMYDA-RELOAD (← links)
- High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial (← links)
- Vertebral artery dissection (← links)
- Research on Adverse Drug events And Reports (← links)
- Adenosine A3 receptor (← links)
- P2RY1 (← links)
- P2RY2 (← links)
- P2RY4 (← links)
- P2RY6 (← links)
- P2RY8 (← links)
- P2RY10 (← links)
- P2RY11 (← links)
- P2RY13 (← links)
- P2RY14 (← links)
- P2RX7 (← links)
- Nephrotoxic drugs (← links)
- Otamixaban (← links)
- P2RX5 (← links)
- P2RX2 (← links)
- P2RX4 (← links)
- PCI complications: thrombocytopenia (← links)
- Xience V stent continues to demonstrate superior efficacy over the Taxus stent up to 2 years in the SPIRIT III trial (← links)
- Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel (← links)
- PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference (← links)
- P2RX1 (← links)
- P2RX3 (← links)
- P2RX6 (← links)
- Idraparinux (← links)
- ST elevation myocardial infarction beta blocker therapy (← links)
- Thrombus Aspiration is Associated with Improved 1 Year Mortality Rates in STEMI Patients: the Results of the 1 Year TAPAS Follow-Up Study (← links)
- ACTIVE W Trial (← links)
- Plavix (redirect page) (← links)
- Multivessel coronary artery disease (← links)
- Antithrombin therapy to support PCI (← links)
- List of drugs: Pj-Pra (← links)
- Paroxetine drug interactions (← links)
- Phenytoin drug interactions (← links)
- Hydrocodone drug interactions (← links)
- Glimepiride drug interactions (← links)
- Celecoxib drug interactions (← links)
- Aggrenox drug interactions (← links)
- Amlodipine and Atorvastatin drug interactions (← links)
- Naproxen drug interactions (← links)
- Duloxetine drug interactions (← links)
- Clarithromycin drug interactions (← links)
- The list of drugs may cause diarrhea (← links)
- Bristol-Myers Squibb (← links)
- Management of the thrombotic lesion (← links)
- Nosebleed (patient information) (← links)
- Peripheral arterial disease (patient information) (← links)
- Sticky platelet syndrome (← links)
- Clopidogrel detailed information (redirect to section "Pharmacology") (← links)
- WikiDoc state of the art review on Clopidogrel (redirect page) (← links)
- Paroxetine drug interactions (← links)
- Phenytoin drug interactions (← links)
- Hydrocodone drug interactions (← links)
- Glimepiride drug interactions (← links)
- Ramatroban (← links)
- Clopidogrel drug interactions (redirect to section "Drug Interactions") (← links)
- Celecoxib drug interactions (← links)
- Cilostazol (← links)
- Amiodarone (tablet) (← links)
- Aggrenox drug interactions (← links)
- Amlodipine and Atorvastatin drug interactions (← links)
- Epoprostenol detailed information (← links)
- Tenecteplase detailed information (← links)
- Naproxen drug interactions (← links)
- Duloxetine drug interactions (← links)
- Coronary revascularization (← links)
- Clarithromycin drug interactions (← links)
- Clopidogrel indications (redirect to section "Adult Indications and Dosage") (← links)
- Clopidogrel contraindications (redirect to section "Contraindications") (← links)
- Clopidogrel side effects (redirect to section "Adverse Reactions") (← links)
- Clopidogrel precautions (redirect to section "Precautions") (← links)
- Clopidogrel overdose (redirect to section "Overdosage") (← links)
- Clopidogrel instructions for administration (redirect to section "Administration and Monitoring") (← links)
- Clopidogrel how supplied (redirect to section "How Supplied") (← links)
- Clopidogrel pharmacokinetics and molecular data (redirect to section "Pharmacokinetics") (← links)
- The On-Time 2 trial Suggests Benefit with Early Administration of Tirofiban in the Ambulance following Acute Myocardial Infarction. (← links)
- Adenosine A2A receptor (← links)
- ST elevation myocardial infarction epidemiology and demographics (← links)
- HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study (← links)
- High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study (← links)
- Unstable angina non ST elevation myocardial infarction overview (← links)
- The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIb Guidelines (← links)
- Thienopyridine (← links)
- The list of drugs may cause diarrhea (← links)
- Aspirin desensitization (← links)
- Antithrombotic (← links)
- ST elevation myocardial infarction anticoagulant and antithrombotic therapy (← links)
- Clopidogrel resistance (← links)
- Unstable angina non ST elevation myocardial infarction immediate management (← links)
- Unstable angina / non ST elevation myocardial infarction antiplatelet therapy (← links)
- Unstable angina non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy (← links)
- Unstable angina non ST elevation myocardial infarction recommendations for PCI (← links)
- Unstable angina non ST elevation myocardial infarction recommendations for CABG (← links)
- Unstable angina non ST elevation myocardial infarction initial conservative versus initial invasive strategies (← links)
- Unstable angina non ST elevation myocardial infarction medical regimen and use of medications (← links)
- VerifyNow (← links)
- Unstable angina / non ST elevation myocardial infarction drug and substance abusers (← links)
- Bristol-Myers Squibb (← links)
- Atrial fibrillation pharmacological treatment (← links)
- Vitamin K antagonist (← links)
- Rivaroxaban (← links)
- Results of the ATLAS ACS-TIMI 46 Study Published in The Lancet (← links)
- Angina (patient information) (← links)
- Prasugrel approved by the FDA (← links)
- Heart attack (patient information) (← links)
- Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial (← links)
- Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study (← links)
- Ticagrelor (← links)
- Angina pectoris (patient information) (← links)
- Predictors of coronary stent thrombosis (← links)
- Stroke (patient information) (← links)
- Atrial fibrillation (patient information) (← links)
- Secondary Prevention of Coronary Artery Disease (← links)
- Dual antiplatelet therapy (← links)
- Left main intervention (← links)
- Management of the thrombotic lesion (← links)
- Vorapaxar (← links)
- Determinants of Sapheous Vein Graft Patency (← links)
- Clinical Pharmacology of Dabigatran (← links)
- Atrial fibrillation anticoagulation (← links)
- Atrial fibrillation overview of treatment (← links)
- CHA2DS2-VASc Score (← links)
- Unstable angina non ST elevation myocardial infarction aspirin therapy (← links)
- Unstable angina non ST elevation myocardial infarction thienopyridines (← links)
- Unstable angina non ST elevation myocardial infarction GPIIb/IIIa inhibitor (← links)
- Treatment of coronary stent thrombosis (← links)
- Prevention of ST (← links)
- Stent thrombosis treatment (← links)
- Stent thrombosis prevention (← links)
- Stent thrombosis risk factors (← links)
- Atrial septal defect overview (← links)
- Atrial septal defect surgical closure (← links)
- Atrial septal defect percutaneous closure (← links)
- Atrial fibrillation natural history, complications and prognosis (← links)
- Unstable angina non ST elevation myocardial infarction long term anticoagulation therapy (← links)
- Unstable angina non ST elevation myocardial infarction complications of bleeding and transfusion prevention (← links)
- Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy (← links)
- Chronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients (← links)
- Chronic stable angina treatment aspirin (← links)
- Chronic stable angina treatment clopidogrel (← links)
- Chronic stable angina guidelines for pharmacotherapy to improve prognosis and reduce symptoms (← links)
- Chronic stable angina medical therapy (← links)
- Chronic stable angina percutaneous coronary intervention versus coronary artery bypass grafting (← links)
- Chronic stable angina (patient information) (← links)
- Coronary artery bypass surgery aspirin and clopidogrel (← links)
- Percutaneous coronary intervention (patient information) (← links)
- Coronary heart disease (patient information) (← links)
- Unstable angina / non ST elevation myocardial infarction (patient information) (← links)
- Thrombotic thrombocytopenic purpura (patient information) (← links)
- Carotid artery stenosis (patient information) (← links)
- Peripheral angioplasty discharge instructions (patient information) (← links)
- Multi-infarct dementia (patient information) (← links)
- Mitral valve surgery - minimally invasive (patient information) (← links)
- Mitral valve surgery - open (patient information) (← links)
- Rivaroxaban FDA review of ROCKET AF data (← links)
- Stroke ischemic treatment (← links)
- Atrial septal defect post surgical follow up (← links)
- Atrial septal defect video showing percutaneous repair (← links)
- Chronic stable angina revascularization complications of percutaneous coronary intervention (← links)
- Chronic stable angina revascularization adjunctive pharmacotherapy for percutaneous coronary intervention (← links)
- Congestive heart failure and thrombosis (← links)
- Clopidogrel dosing and role of genetics: ELEVATE-TIMI 56 trial (← links)
- Aortic valve surgery - minimally invasive (patient information) (← links)
- Aortic valve surgery - open (patient information) (← links)
- Coronary artery bypass surgery postoperative antiplatelet therapy (← links)
- Bronchitis causes (← links)
- Peptic ulcer causes (← links)
- Cardiac amyloidosis differential diagnosis (← links)
- Congestive heart failure anticoagulants (← links)
- Aortic regurgitation surgery valve selection (← links)
- Pain causes (← links)
- Rectal bleeding causes (← links)
- Headacheold (← links)
- Headache causes (← links)
- Drug allergy causes (← links)
- Cardiogenic shock overview (← links)
- Cardiogenic shock primary prevention (← links)
- Coronary heart disease medical therapy (← links)
- Epistaxis causes (← links)
- Intracranial hemorrhage causes (← links)
- Diarrhea causes (← links)
- Atrial flutter (patient information) (← links)
- Antiphospholipid syndrome medical therapy (← links)
- Atrial fibrillation in acute coronary syndromes (← links)
- Mesenteric ischemia secondary prevention (← links)
- Hematemesis causes (← links)
- Gastritis causes (← links)
- Melena causes (← links)
- Hematochezia causes (← links)
- Thrombotic thrombocytopenic purpura causes (← links)
- Thrombotic thrombocytopenic purpura secondary prevention (← links)
- Neutropenia causes (← links)
- Peripheral arterial disease medical therapy (← links)
- Peripheral arterial disease (patient information) (← links)
- Carotid artery stenosis medical therapy (← links)
- Carotid artery stenosis surgery (← links)
- Carotid artery stenosis secondary prevention (← links)
- Coronary artery bypass surgery bleeding/transfusion (← links)
- Vertebral artery disease (← links)
- Upper gastrointestinal bleeding causes (← links)
- Upper gastrointestinal bleeding medical therapy (← links)
- Unstable angina NSTEMI Antiplatelet therapy recommendations (← links)
- Coronary heart disease secondary prevention antiplatelet agents/anticoagulants (← links)
- Percutaneous coronary intervention overview (← links)
- Percutaneous coronary intervention oral antiplatelet therapy (← links)
- Percutaneous coronary intervention post-procedural antiplatelet therapy (← links)
- Percutaneous coronary intervention clopidogrel genetic testing (← links)
- Percutaneous coronary intervention platelet function testing (← links)
- Risk reduction after PCI (← links)
- Coronary artery bypass surgery post-operative care and complications (← links)
- Drug induced liver injury pathophysiology (← links)
- Hepatotoxicity pathophysiology (← links)
- Atrial septal defect ostium secundum surgical closure (← links)
- Atrial septal defect ostium secundum percutaneous closure (← links)
- Atrial septal defect ostium primum surgical closure (← links)
- Atrial septal defect ostium primum percutaneous closure (← links)
- Ischemic stroke medical therapy (← links)
- Dizziness causes (← links)
- Gangrene overview (← links)
- Gangrene medical therapy (← links)
- Pedal edema causes (← links)
- Intraprocedural stent thrombosis (← links)
- WBR0754 (← links)
- WBR0880 (← links)
- Vertebrobasilar insufficiency primary prevention (← links)
- Unstable angina/ NSTEMI resident survival guide (← links)
- AHA/ASA guideline recommendations for prevention of stroke in women prevention (← links)
- Cangrelor (← links)
- STEMI resident survival guide (← links)
- Clopidogrel indications and usage (redirect to section "Adult Indications and Dosage") (← links)
- Clopidogrel dosage and administration (redirect to section "Adult Indications and Dosage") (← links)
- Clopidogrel dosage forms and strengths (redirect to section "How Supplied") (← links)
- Clopidogrel warnings and precautions (redirect to section "Warnings") (← links)
- Clopidogrel adverse reactions (redirect to section "Adverse Reactions") (← links)
- Clopidogrel use in specific populations (redirect to section "Use in Specific Populations") (← links)
- Clopidogrel description (redirect to section "Structure") (← links)
- Clopidogrel overdosage (redirect to section "Overdosage") (← links)
- Clopidogrel labels and packages (redirect to section "Package and Label Display Panel") (← links)
- Clopidogrel clinical pharmacology (redirect to section "Pharmacology") (← links)
- Clopidogrel nonclinical toxicology (redirect to section "Nonclinical Toxicology") (← links)
- Clopidogrel how supplied storage and handling (redirect to section "How Supplied") (← links)
- Clopidogrel patient counseling information (redirect to section "Patient Counseling Information") (← links)
- Clopidogrel clinical studies (redirect to section "Clinical Studies") (← links)
- Sandbox/AIRSG (← links)
- Aortic regurgitation resident survival guide (← links)
- Aortic stenosis resident survival guide (← links)
- Bleeding disorder resident survival guide (← links)
- Brilinta tablet/adult indications and dosage (← links)
- Brilinta tablet/warnings (← links)
- Direct Xa inhibitor (← links)
- Sandbox AF2014 (← links)
- Peripheral artery disease resident survival guide (← links)
- Sandbox/MS (← links)
- Sandbox spb2013 (← links)
- Perioperative bleeding (← links)
- Bleeding perioperative bleeding management in specific surgeries (← links)
- Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy (← links)
- Bleeding reversal of anticoagulation and antiplatelet in active bleed (← links)
- Clopidogrel Bisulfate (redirect page) (← links)
- Sandbox Ticagrelor (← links)
- Sandbox Rim (← links)
- Rivaroxaban (patient information) (← links)
- Tirofiban (← links)
- Fluindione (← links)
- Darexaban (← links)
- Esomeprazole sodium (← links)
- Dexlansoprazole (← links)
- Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention (← links)
- Naproxen and esomeprazole magnesium (← links)
- Carbasalate (← links)
- Reviparin sodium (← links)
- Cardiac catheterization pre-procedure evaluation resident survival guide (← links)
- Drug project list of medications (← links)
- Pantoprazole (injection) (← links)
- Esomeprazole (oral) (← links)
- Unstable angina / non ST elevation myocardial infarction substance abuse (← links)
- Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update (← links)
- Secondary Prevention Guidelines Recommendations (← links)
- Management of Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease (← links)
- Patients With Cervical Artery Dissection (← links)
- Management of Patients Undergoing Carotid Artery Stenting (← links)
- ST elevation myocardial infarction fibrinolysis (← links)
- Medical therapy for lower extremity peripheral arterial disease (← links)
- Sandbox:Hematuria overview (← links)
- Sandbox:tavr (← links)
- TAVR Procedure guide (← links)
- Post TAVR management (← links)
- Patiromer (← links)
- Spontaneous coronary artery dissection overview (← links)
- Spontaneous coronary artery dissection medical therapy (← links)
- Lower gastrointestinal bleeding laboratory findings (← links)
- Drug project high-priority medications (← links)
- Equilibrative nucleoside transporter 2 (← links)
- LPAR6 (← links)
- Concentrative nucleoside transporter 2 (← links)
- Concentrative nucleoside transporter 1 (← links)
- Adenosine A2B receptor (← links)
- Acute diarrhea causes (← links)
- Wild-type (senile) amyloidosis differential diagnosis (← links)
- Primary amyloidosis differential diagnosis (← links)
- Familial amyloidosis differential diagnosis (← links)
- Unstable angina / non ST elevation myocardial infarction and women (← links)
- Unstable angina / non ST elevation myocardial infarction and substance abuse (← links)
- Sandbox:Sara.Zand (← links)
- Neurologic Disorders and COVID-19 (← links)
- COVID-19-associated stroke (← links)
- COVID-19-associated myocardial infarction (← links)
- COVID-19-associated spontaneous coronary artery dissection (← links)
- Template:Antithrombotics (← links)
- Template:Clopidogrel (← links)
- Template:Purine receptor modulators (← links)